相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of potential non-nucleoside MraY inhibitors for tuberculosis chemotherapy using structure-based virtual screening
Pankaj Pandey et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex
Changrui Xing et al.
CELL (2020)
Cannabinoids, Blood-Brain Barrier, and Brain Disposition
Fabrizio Calapai et al.
PHARMACEUTICS (2020)
Optimization Rules for SARS-CoV-2 M-pro Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site
Shana Stoddard et al.
VIRUSES-BASEL (2020)
OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules
Katarina Roos et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2019)
Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?
David Ramirez et al.
MOLECULES (2018)
GPCRM: a homology modeling web service with triple membrane-fitted quality assessment of GPCR models
Przemyslaw Miszta et al.
NUCLEIC ACIDS RESEARCH (2018)
One-step, stereoselective synthesis of octahydrochromanes via the Prins reaction and their cannabinoid activities
Shuneize Slater et al.
TETRAHEDRON LETTERS (2018)
Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists
Pankaj Pandey et al.
MOLECULES (2018)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Debra A. Kendall et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Phytocannabinoids: a unified critical inventory
Lumir Ondrej Hanus et al.
NATURAL PRODUCT REPORTS (2016)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
The role of endocannabinoids system in fatty liver disease and therapeutic potentials
Khalid A. Alswat
SAUDI JOURNAL OF GASTROENTEROLOGY (2013)
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
Federica Barutta et al.
DIABETES (2011)
Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia
Wei Xiong et al.
NATURE CHEMICAL BIOLOGY (2011)
Cannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice
Courtney D. Netherland et al.
ATHEROSCLEROSIS (2010)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Epik:: a software program for pK a prediction and protonation state generation for drug-like molecules
John C. Shelley et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors
Onintza Sagredo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Pharmacological effects of ephedrine alkaloids on human α1- and α2-adrenergic receptor subtypes
Guoyi Ma et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
Jennifer L. Shoemaker et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
First synthesis of antimalarial Machaeriols A and B
AG Chittiboyina et al.
TETRAHEDRON LETTERS (2004)
Antimalarial (+)-trans-hexahydrodibenzopyran derivatives from Machaerium multiflorum
I Muhammad et al.
JOURNAL OF NATURAL PRODUCTS (2001)
分享论文
